Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial-Reference-Cited by-同舟云学术

Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial

Published:2023-03 Issue:3 Volume:8 Page:228-241
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Liou Jyh-Ming,Jiang Xiao-Tao,Chen Chieh-Chang,Luo Jiing-Chyuan,Bair Ming-Jong,Chen Po-Yueh,Chou Chu-Kuang,Fang Yu-Jen,Chen Mei-Jyh,Chen Chien-Chuan,Lee Ji-Yuh,Yang Tsung-Hua,Yu Chien-Chun,Kuo Chia-Chi,Chiu Min-Chin,Chen Chi-Yi,Shun Chia-Tung,Hu Wen-Hao,Tsai Min-Horn,Hsu Yao-Chun,Tseng Cheng-Hao,Chang Chi-Yang,Lin Jaw-Town,El-Omar Emad M,Wu Ming-Shiang,Wu Chun-Ying,Lee Yi-Chia,Tseng Ping-Huei,Wu Jeng-Yih,Tai Chi-Ming,Lee Ching-Tai,Wang Wen-Lun

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference32 articles.

1. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis;Murray;Lancet,2022

2. Family history of gastric cancer and Helicobacter pylori treatment;Choi;N Engl J Med,2020

3. Helicobacter pylori therapy for the prevention of metachronous gastric cancer;Choi;N Engl J Med,2018

4. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus;Liou;Gut,2020

5. Population screening and treatment of Helicobacter pylori infection;O'Connor;Nat Rev Gastroenterol Hepatol,2017

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Where are we with gastric cancer screening in Europe in 2024?;Gut;2024-09-04

2. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection;American Journal of Gastroenterology;2024-09

3. Vonoprazan Dual or Triple Therapy Versus Bismuth‐Quadruple Therapy as First‐Line Therapy for Helicobacter pylori Infection: A Three‐Arm, Randomized Clinical Trial;Helicobacter;2024-09

4. Peptic ulcer disease;The Lancet;2024-07

5. Rapid diagnosis and precision treatment of Helicobacter pylori infection in clinical settings;Critical Reviews in Microbiology;2024-06-24